Altis Biosystems

Website

Altis Biosystems, Inc.

9 Investors
Biotechnology, Drug Discovery
DURHAM, NC

Altis Biosystems, Inc. is a pioneering biotechnology firm based in North Carolina, dedicated to enhancing preclinical research through the development of innovative human cell-based models that accurately replicate the gastrointestinal (GI) tract. By providing superior alternatives to traditional cell line and animal models, Altis facilitates improved drug discovery and development, ensuring better predictive insights and reducing reliance on animal testing.

Products & Team

RepliGut® System

In Vitro ModelsSeed

The RepliGut® System is a groundbreaking collection of in vitro models derived from human intestinal stem cells that replicate the structure and function of the human intestine. It is designed to advance preclinical research by providing more human-relevant data for drug efficacy, toxicity, and bioavailability assessments.

Value Proposition

The RepliGut® System addresses the limitations of traditional animal models by providing cost-effective, scalable research tools that yield accurate data essential for preclinical drug testing.

Pain Points

Challenges in accurately predicting drug efficacy and safety profiles using traditional models, high failure rates in clinical trials, and regulatory pressures to provide human-derived data.

RepliGut® Planar for drug-induced toxicity and permeability assaysRepliGut® Crypt to model intestinal crypt cell developmentRepliGut® Kits for customized experimental setup with essential materials included
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
DURHAM, NC
Primary headquarters

Funding History

Total Raised:
$2.1M
E

Equity Offering

March 2025
$2.3M
Target
Use of Proceeds
None other than payments of salary in the ordinary course of business to certain of the parties named in response to Item 3.
Progress
95%
Raised
$2.1M
Target
$2.3M
#000179989225000001